Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Roberto Alfonso
Observed name:
Roberto Alfonso-Dunn
Institution:
Tisch MS Research Center of New York
Observed institutions:
National Institutes of Health,
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias,
Centro Nacional de Biotecnología,
National Institute of Allergy and Infectious Diseases,
Tisch MS Research Center of New York
ORCID:
0000-0001-7844-5454
Observed ORCID:
0000-0001-7844-5454
OpenAlex ID:
A5029023848
CHD6 chromatin remodeler is a negative modulator of influenza virus replication that relocates to inactive chromatin upon infection
2011
·
Roberto Alfonso
, Thomas Lutz
, et al.
·
Cellular Microbiology
·
49
PDF
Transcriptional Elongation of HSV Immediate Early Genes by the Super Elongation Complex Drives Lytic Infection and Reactivation from Latency
2017
·
Roberto Alfonso-Dunn
, Anne-Marie W. Turner
, et al.
·
Cell Host & Microbe
·
39
PDF
Influenza virus polymerase: Functions on host range, inhibition of cellular response to infection and pathogenicity
2015
·
Ariel Rodriguez-Frandsen
, Roberto Alfonso
, et al.
·
Virus Research
·
35
Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies
2022
·
Roberto Alfonso-Dunn
, Jerry Lin
, et al.
·
Frontiers in Immunology
·
28
Inhibition of the Super Elongation Complex Suppresses Herpes Simplex Virus Immediate Early Gene Expression, Lytic Infection, and Reactivation from Latency
2020
·
Roberto Alfonso-Dunn
, Jesse H. Arbuckle
, et al.
·
mBio
·
16
CHD6, a Cellular Repressor of Influenza Virus Replication, Is Degraded in Human Alveolar Epithelial Cells and Mice Lungs during Infection
2013
·
Roberto Alfonso
, Ariel Rodriguez
, et al.
·
Journal of Virology
·
13
Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study
2023
·
Roberto Alfonso-Dunn
, Jerry Lin
, et al.
·
Frontiers in Immunology
·
3
Immunological Response to COVID-19 Vaccine Boosters in Multiple Sclerosis Patients Treated with anti-CD20 Therapy (S21.001)
2023
·
Antonia De Oliveira
, Joyce Lei
, et al.
·
Neurology
Strong T-cell activation in response to SARS-CoV-2 vaccination in patients with multiple sclerosis on B-cell depleting therapies (P1-1.Virtual)
2022
·
Joyce Lei
, Vanessa Kirschner
, et al.
·
Neurology
Show more works
View as search
Works count:
9
Citation count:
183
H-index:
6
I10-index:
6
Year
Topic
Type